Psychiatric Considerations in Pediatric Patients With Brain Tumors

Jessie Benson, BBA; Ashish Sarangi, MD

Prim Care Companion CNS Disord 2022;24(6):21r03228

ABSTRACT

Objective: Adolescents diagnosed with brain or central nervous system tumors face elevated levels of depression and anxiety compared to the general pediatric population. The objective of this review was to explore factors associated with elevated depression and anxiety symptoms in these patients, as well as various currently recommended interventions.

Data Sources: Articles were searched in PubMed and filtered to select for the following MeSH keywords: brain neoplasm, mental health, behavioral symptom, mental disorder AND (child* OR adolescen* OR teen* OR youth OR pediatr*). Articles were limited to those published in English between 2000 and 2020.

Study Selection: A total of 1,537 articles were retrieved, and 36 studies were reviewed. Articles were selected if they pertained to human subjects, specifically adolescents aged ≤ 18 years. Additionally, only articles about depression and anxiety were included. Symptoms of depression and anxiety before a brain tumor diagnosis or as symptoms of a possible brain tumor were excluded.

Data Extraction: Articles were screened by title and abstract as they pertained to depression and anxiety in patients diagnosed with brain tumors in adolescence. Data extracted included information about risk factors associated with depression and anxiety, interventions, and pharmacologic considerations.

Results: Factors associated with increased depressive and anxiety symptoms include intensity of cancer treatment, female sex, and brain tumor diagnosis. Pediatric brain tumor patients also experience elevated antidepressant prescription rates. When treating depression and anxiety in these patients, it is also important to focus on multifaceted interventions like behavioral and communication therapies, as the nature of brain tumors can affect psychological, social, and cognitive abilities.

Conclusions: Depression and anxiety can have long-lasting effects on pediatric brain tumor patients and put them at risk for developing other psychosocial problems. Therefore, it is important to recognize factors contributing to depression and anxiety as well as potential interventions.

Continue Reading...

Did you know members enjoy unlimited free PDF downloads as part of their subscription? Subscribe today for instant access to this article and our entire library in your preferred format. Alternatively, you can purchase the PDF of this article individually.

Subscribe Now

Already a member? Login

Purchase PDF for $40

Members enjoy free PDF downloads on all articles. Join today

References (47)

Udaka YT, Packer RJ. Pediatric brain tumors. Neurol Clin. 2018;36(3):533–556. PubMed CrossRef
Ostrom QT, Patil N, Cioffi G, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013–2017. Neuro-oncol. 2020;22(suppl 1):iv1–iv96. PubMed CrossRef
Gerber NU, Zehnder D, Zuzak TJ, et al. Outcome in children with brain tumors diagnosed in the first year of life: long-term complications and quality of life. Arch Dis Child. 2008;93(7):582–589. PubMed CrossRef
Shah SS, Dellarole A, Peterson EC, et al. Long-term psychiatric outcomes in pediatric brain tumor survivors. Childs Nerv Syst. 2015;31(5):653–663. PubMed CrossRef
Ghandour RM, Sherman LJ, Vladutiu CJ, et al. Prevalence and treatment of depression, anxiety, and conduct problems in US children. J Pediatr. 2019;206:256–267.e3. PubMed CrossRef
Zada G, Kintz N, Pulido M, et al. Prevalence of neurobehavioral, social, and emotional dysfunction in patients treated for childhood craniopharyngioma: a systematic literature review. PLoS One. 2013;8(11):e76562. PubMed CrossRef
Oh Y, Seo H, Sung KW, et al. The effects of attention problems on psychosocial functioning in childhood brain tumor survivors: a 2-year postcraniospinal irradiation follow-up. J Pediatr Hematol Oncol. 2017;39(2):e46–e53. PubMed CrossRef
Waber DP, Pomeroy SL, Chiverton AM, et al. Everyday cognitive function after craniopharyngioma in childhood. Pediatr Neurol. 2006;34(1):13–19. PubMed CrossRef
Kahalley LS, Wilson SJ, Tyc VL, et al. Are the psychological needs of adolescent survivors of pediatric cancer adequately identified and treated? Psychooncology. 2013;22(2):447–458. PubMed CrossRef
Alibas H, Uluc K, Kahraman Koytak P, et al. Evaluation of depressive mood and cognitive functions in patients with acromegaly under somatostatin analogue therapy. J Endocrinol Invest. 2017;40(12):1365–1372. PubMed CrossRef
Ross L, Johansen C, Dalton SO, et al. Psychiatric hospitalizations among survivors of cancer in childhood or adolescence. N Engl J Med. 2003;349(7):650–657. PubMed CrossRef
Kristiansen I, Strinnholm M, Strömberg B, et al. Clinical characteristics, long-term complications and health-related quality of life (HRQoL) in children and young adults treated for low-grade astrocytoma in the posterior fossa in childhood. J Neurooncol. 2019;142(1):203–210. PubMed CrossRef
Moitra E, Armstrong CL. Neural substrates for heightened anxiety in children with brain tumors. Dev Neuropsychol. 2013;38(5):337–351. PubMed CrossRef
Patel SK, Mullins WA, O’Neil SH, et al. Neuropsychological differences between survivors of supratentorial and infratentorial brain tumors. J Intellect Disabil Res. 2011;55(1):30–40. PubMed CrossRef
Pastore V, Colombo K, Villa F, et al. Psychological and adjustment problems due to acquired brain lesions in pre-school-aged patients. Brain Inj. 2013;27(6):677–684. PubMed CrossRef
Varela M, Liakopoulou M, Alexiou GA, et al. Presurgical neuropsychological and behavioral evaluation of children with posterior fossa tumors. J Neurosurg Pediatr. 2011;8(6):548–553. PubMed CrossRef
Mabbott DJ, Spiegler BJ, Greenberg ML, et al. Serial evaluation of academic and behavioral outcome after treatment with cranial radiation in childhood. J Clin Oncol. 2005;23(10):2256–2263. PubMed CrossRef
Schultz KAP, Ness KK, Whitton J, et al. Behavioral and social outcomes in adolescent survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2007;25(24):3649–3656. PubMed CrossRef
Brackett J, Krull KR, Scheurer ME, et al. Antioxidant enzyme polymorphisms and neuropsychological outcomes in medulloblastoma survivors: a report from the Childhood Cancer Survivor Study. Neuro-oncol. 2012;14(8):1018–1025. PubMed CrossRef
Brinkman TM, Palmer SL, Chen S, et al. Parent-reported social outcomes after treatment for pediatric embryonal tumors: a prospective longitudinal study. J Clin Oncol. 2012;30(33):4134–4140. PubMed CrossRef
Meyer EA, Kieran MW. Psychological adjustment of ‘surgery-only’ pediatric neuro-oncology patients: a retrospective analysis. Psychooncology. 2002;11(1):74–79. PubMed CrossRef
Riquin E, Dinomais M, Malka J, et al. Psychiatric and psychologic impact of surgery while awake in children for resection of brain tumors. World Neurosurg. 2017;102:400–405. PubMed CrossRef
Barrera M, Schulte F, Spiegler B. Factors influencing depressive symptoms of children treated for a brain tumor. J Psychosoc Oncol. 2008;26(1):1–16. PubMed CrossRef
Barrera M, Schulte F. A group social skills intervention program for survivors of childhood brain tumors. J Pediatr Psychol. 2009;34(10):1108–1118. PubMed CrossRef
Gunn ME, Mört S, Arola M, et al. Quality of life and late-effects among childhood brain tumor survivors: a mixed method analysis. Psychooncology. 2016;25(6):677–683. PubMed CrossRef
Zebrack BJ, Gurney JG, Oeffinger K, et al. Psychological outcomes in long-term survivors of childhood brain cancer: a report from the childhood cancer survivor study. J Clin Oncol. 2004;22(6):999–1006. PubMed CrossRef
Memmesheimer RM, Lange K, Dölle M, et al. Psychological well-being and independent living of young adults with childhood-onset craniopharyngioma. Dev Med Child Neurol. 2017;59(8):829–836. PubMed CrossRef
Brinkman TM, Liptak CC, Delaney BL, et al. Suicide ideation in pediatric and adult survivors of childhood brain tumors. J Neurooncol. 2013;113(3):425–432. PubMed CrossRef
Irestorm E, Tonning Olsson I, Johansson B, et al. Cognitive fatigue in relation to depressive symptoms after treatment for childhood cancer. BMC Psychol. 2020;8(1):31. PubMed CrossRef
Mehren A, Özyurt J, Zu Klampen P, et al. Self- and informant-rated apathy in patients with childhood-onset craniopharyngioma. J Neurooncol. 2018;140(1):27–35. PubMed CrossRef
Laffond C, Dellatolas G, Alapetite C, et al. Quality-of-life, mood and executive functioning after childhood craniopharyngioma treated with surgery and proton beam therapy. Brain Inj. 2012;26(3):270–281. PubMed CrossRef
Papazoglou A, King TZ, Morris RD, et al. Parent report of attention problems predicts later adaptive functioning in children with brain tumors. Child Neuropsychol. 2009;15(1):40–52. PubMed CrossRef
Pao M, Ballard ED, Rosenstein DL, et al. Psychotropic medication use in pediatric patients with cancer. Arch Pediatr Adolesc Med. 2006;160(8):818–822. PubMed CrossRef
Johannsdottir IM, Karlstad Ø, Loge JH, et al. Prescriptions of antidepressants to survivors of cancer in childhood, adolescence, and young adulthood: a population-based study. J Adolesc Young Adult Oncol. 2017;6(1):120–126. PubMed CrossRef
Phipps S, Buckholdt KE, Fernandez L, et al. Pediatric oncologists’ practices of prescribing selective serotonin reuptake inhibitors (SSRIs) for children and adolescents with cancer: a multi-site study. Pediatr Blood Cancer. 2012;58(2):210–215. PubMed CrossRef
Rooney A, Grant R. Pharmacological treatment of depression in patients with a primary brain tumor. Cochrane Database Syst Rev. 2013;2013(5):CD006932. PubMed CrossRef
Zhuo C, Xun Z, Hou W, et al. Surprising anticancer activities of psychiatric medications: old drugs offer new hope for patients with brain cancer. Front Pharmacol. 2019;10:1262. PubMed CrossRef
Poggi G, Liscio M, Galbiati S, et al. Brain tumors in children and adolescents: cognitive and psychological disorders at different ages. Psychooncology. 2005;14(5):386–395. PubMed CrossRef
Cheung AT, Li WHC, Ho KY, et al. Efficacy of musical training on psychological outcomes and quality of life in Chinese pediatric brain tumor survivors. Psychooncology. 2019;28(1):174–180. PubMed CrossRef
Ehrstedt C, Rydell AM, Gabert Hallsten M, et al. Cognition, health-related quality of life, and mood in children and young adults diagnosed with a glioneuronal tumor in childhood. Epilepsy Behav. 2018;83:59–66. PubMed CrossRef
Adduci A, Jankovic M, Strazzer S, et al. Parent-child communication and psychological adjustment in children with a brain tumor. Pediatr Blood Cancer. 2012;59(2):290–294. PubMed CrossRef
Desjardins L, Barrera M, Schulte F, et al. Predicting social withdrawal, anxiety and depression symptoms in pediatric brain tumor survivors. J Psychosoc Oncol. 2019;37(1):22–36. PubMed CrossRef
Tsai YL, Tsai SC, Yen SH, et al. Efficacy of therapeutic play for pediatric brain tumor patients during external beam radiotherapy. Childs Nerv Syst. 2013;29(7):1123–1129. PubMed CrossRef
Barton MK. Drug interactions in cancer patients receiving antidepressants are common, researchers report. CA Cancer J Clin. 2011;61(5):283–284. PubMed CrossRef
Grassi L, Nanni MG, Rodin G, et al. The use of antidepressants in oncology: a review and practical tips for oncologists. Ann Oncol. 2018;29(1):101–111. PubMed CrossRef
Bielecka AM, Obuchowicz E. Antidepressant drugs can modify cytotoxic action of temozolomide. Eur J Cancer Care (Engl). 2017;26(5):e12551. PubMed CrossRef
Peterson RK, McKeown T, Tabori U, et al. Neuropsychological impact of trametinib in pediatric low-grade glioma: a case series. Pediatr Blood Cancer. 2020;67(12):e28690. PubMed CrossRef